+Search query
-Structure paper
| Title | Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5. |
|---|---|
| Journal, issue, pages | Antiviral Res., Vol. 216, Page 105654-105654, Year 2023 |
| Publish date | Dec 19, 2021 (structure data deposition date) |
Authors | Thomas R Lane / Jianing Fu / Barbara Sherry / Bart Tarbet / Brett L Hurst / Olga Riabova / Elena Kazakova / Anna Egorova / Penny Clarke / J Smith Leser / Joshua Frost / Michael Rudy / Kenneth L Tyler / Thomas Klose / Alexandrina S Volobueva / Svetlana V Belyaevskaya / Vladimir V Zarubaev / Richard J Kuhn / Vadim Makarov / Sean Ekins / ![]() |
| PubMed Abstract | Enteroviruses (EV) cause a number of life-threatening infectious diseases. EV-D68 is known to cause respiratory illness in children that can lead to acute flaccid myelitis. Coxsackievirus B5 (CVB5) ...Enteroviruses (EV) cause a number of life-threatening infectious diseases. EV-D68 is known to cause respiratory illness in children that can lead to acute flaccid myelitis. Coxsackievirus B5 (CVB5) is commonly associated with hand-foot-mouth disease. There is no antiviral treatment available for either. We have developed an isoxazole-3-carboxamide analog of pleconaril (11526092) which displayed potent inhibition of EV-D68 (IC 58 nM) as well as other enteroviruses including the pleconaril-resistant Coxsackievirus B3-Woodruff (IC 6-20 nM) and CVB5 (EC 1 nM). Cryo-electron microscopy structures of EV-D68 in complex with 11526092 and pleconaril demonstrate destabilization of the EV-D68 MO strain VP1 loop, and a strain-dependent effect. A mouse respiratory model of EV-D68 infection, showed 3-log decreased viremia, favorable cytokine response, as well as statistically significant 1-log reduction in lung titer reduction at day 5 after treatment with 11526092. An acute flaccid myelitis neurological infection model did not show efficacy. 11526092 was tested in a mouse model of CVB5 infection and showed a 4-log TCID reduction in the pancreas. In summary, 11526092 represents a potent in vitro inhibitor of EV with in vivo efficacy in EV-D68 and CVB5 animal models suggesting it is worthy of further evaluation as a potential broad-spectrum antiviral therapeutic against EV. |
External links | Antiviral Res. / PubMed:37327878 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 2 - 2.7 Å |
| Structure data | ![]() PDB-7t9p: ![]() PDB-7taf: ![]() PDB-7tag: ![]() PDB-7tah: ![]() PDB-7taj: |
| Chemicals | ![]() ChemComp-GFI: ![]() ChemComp-W11: |
| Source |
|
Keywords | VIRUS / EV-D68 / acute flaccid myelitis / AFM / Structural Genomics / Center for Structural Genomics of Infectious Diseases / CSGID / VIRUS/INHIBITOR / inhibitor / antiviral / VIRUS-INHIBITOR complex / antivirial |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links






enterovirus d68
Keywords